Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PANGENOMIC HEALTH A AKTIE und aktueller Aktienkurs. 0500. The Company's initial. Alternativen aus der Peer Group. Revenue in CAD (TTM) 0. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Listing and disclosure documents will be available at on the trading date. *Close price adjusted for splits. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. com; Bello Holdings Inc. Pangenomic Health A Dividenden Chart in CAD Aktien handeln zu Top-Konditionen Aktien, ETFs, Derivate, Kryptos und mehr - jetzt für 0 Euro pro Trade handeln (zzgl. It develops the Nara App, a mental health app that curates natural remedies for individuals to manage and improve mental wellness; Mindleap, a mental health tracker that offers access to audio content, blogs, and professional services for mental well-being; and MUJN that offers. 000 Aktien. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. Company Profile. 07. PanGenomic Health Inc. PanGenomic Health, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Find the latest Pangenomic Health Inc. PanGenomic Health Inc - Vancouver, Canada-based precision health company - Says subsidiary MUJN Diagnostics Inc has launched its brain-derived neurotrophic factor or BDNF mental health biomarker assessment service. 15. 23. The Company's initial focus is to support mental health. News zur PANGENOMIC HEALTH AKTIE und aktueller Realtime-Aktienkurs PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce the results of its Annual. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the "Transaction") of Mindleap Health Inc. 00% As of Oct 29, 2023. PanGenomic Health, Inc. 0 Euro pro Trade handeln (zzgl. is a wholly-owned subsidiary of PanGenomic Health Inc. Juni 2023 29. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. 09 Nov, 2021, 17:34 ET. 21, 2022 /CNW/ - PanGenomic Health Inc. VANCOUVER, BC, Jan. CI. Pangenomic Health Inc. Ltd. View funds that move the market, screen for funds and read relevant news. View the latest PanGenomic Health Inc. 0. For further information: Jerry Lai, Investor Relations, PanGenomic Health Inc, 778 743 4642, [email protected]; Maryam Marissen, President & CEO, PanGenomic Health Inc. /NOT FOR DISTRIBUTION TO U. PanGenomic acquired all of Mindleap's outstanding shares for a purchase price of C$3. Entwicklungen der Börsenkurse und Neuemissionen im Überblick. 2 Ratings. The Company's initial. 57. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic Health and the consideration to be paid to PanGenomic Health. Unternehmens-Meldungen im Überblick: Auf dieser Seite finden Sie alle Finanznachrichten zu Unternehmen in chronologischer Reihenfolge. AQ. Aktienchart mit vielen Chartindikatoren & Vergleichsmöglichkeiten inkl. (NARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Alle DAX Werte in Realtime, Echtzeitkurse und im Push Format. 0,024. mit einem hohe Streubesitz von 87%. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. PanGenomic Health PBC | 211 followers on LinkedIn. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. has been appointed as the Company's AQSE Corporate Adviser. 31 Jan, 2023, 07:30 ET. 01 Nov, 2023, 17:30 ET. PanGenomic Health Inc. ISIN. +0,0001 EUR. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. View the latest NARA company infomation and executive bios. 13. com. euro stoxx 50. PanGenomic will launch the PlantGx platform in Canada and the United States in the summer 2022. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that Maryam Marissen has been. -0,0009 EUR. The Company's initial. Mindleap Health is an app that connects users with mental health treatment, according to a Sept. research and ratings by Barron's. Cookies are used to offer you a better browsing experience and to analyze our traffic. have been approved for listing on the CSE. (NARA. About MUJN Diagnostics. The Company's initial focus is to support mental health. EPS -0. 778 743 4642 info@pangenomic. . Our initial focus is on mental health. Pangenomic Health A Realtimekurs. Pangenomic Health Inc. 20 per Unit, or such higher price as the Canadian Securities Exchange may require. PanGenomic Health Completes Acquisition of Mindleap Health. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed its audited annual financial statements for the fiscal year ended. Forum; Börsenspiel; ARIVA. VANCOUVER, BC, Jan. Ausländisches Symbol. 01 a year ago. Pangenomic Health Inc. 13: Sales - Tangible Book Value 0. 40. NARA Date: December 23, 2022 Is this an updating or amending Notice: Yes No If yes provide date(s) of prior Notices: Issued and Outstanding Securities of Issuer Prior to Issuance: 93,040,972 Pricing Date of news release announcing proposed issuance: N/A orPanGenomic Health Aktie, WKN: A3DN26, ISIN: CA69842E2050 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen In Ihrem Browser ist JavaScript deaktiviert. Pangenomic Health is a digital health platform for plant medicine. 38m; Incorporated 2015; Employees--Location Pangenomic Health Inc 102 3800 Wesbrook Mall VANCOUVER V6S 2L9 Canada CAN;. Beachten Sie. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission. Pangenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. com Maryam Marissen, President & CEO. Die Pangenomic Health Inc Registered Shs -A- Aktie wird unter der ISIN CA69842E2050 an den Börsen Frankfurt, München, Stuttgart,. ISIN: CA69842E2050 · WKN: A3DN26 · SYM: LL30 · Kanada. Volkswagen (VW) vz. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. Nachrichten zur Aktie EGF Theramed Health Corp Registered Shs | A3DMEG | EVAHF. (NARA-CN). Robert Nygren, Executive Chair of PanGenomic Health The LOI contemplates that the Company will acquire all of Mindleap’s outstanding shares for a purchase price of C$4,000,000, payable by the issuance of units at an agreed-upon price of C$0. Risikoanalyse zu PANGENOMIC HEALTH A anhand von objektiven Faktoren wie z. 17, 2023 /CNW/ – PanGenomic Health Inc. stock was issued. 0,0224. PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments. ("PlantGx"), has signed a development partnership. The Company's initial focus is to support mental health. PanGenomic Health Inc. CA69842E2050. A3CN14. Class A (NARA) will release its next earnings report on Aug 31, 2023. Get the latest Pangenomic Health Inc. m. ISIN. PressReader. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health and wellness. Vincent Lum, who has served as. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI") with Interactive Health Inc. 01. Fobi AI Inc. 30: AN Pangenomic Health Inc. Dieser Verlust wurde automatisch als Verlusttopf aus Aktienverkäufen in 2022 übertragen. PanGenomic Health Inc. Name. 22, 2022 /CNW/ - PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Interaktiver realtime Chart zur PanGenomic Health Aktie. David Coffman / George Duxberry. PanGenomic Health Inc. November 21, 2022 at 12:07 p. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. Porsche Automobil vz. Lesen Sie Börsennachrichten und Hintergründe zum Aktienmarkt in Deutschland und der ganzen Welt. Find the latest Pangenomic Health Inc. . nasdaq 100. 2. 4% per year. PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. 11. Pangenomic Health Registered (A) Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie • CA69842E2050 • DAX ±0,00 % MDAX ±0,00 %News zur PANGENOMIC HEALTH AKTIE und aktueller Realtime-Aktienkurs Pangenomic Health Inc: Pangenomic's MJUN rolls out BDNF health. PanGenomic Health has raised a total of. Revenue. Es ist meine erste. )("MUJN Diagnostics"), has signed an agreement to lease space at Psy Integrated. Top 50 Performer Ausland. It provides independent reviews of certain decisions. ca). is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 6M, payable by the issuance of units of PanGenomic at a price of C$0. The Company's initial. Class A reported ― EPS in relation to -C$0. 1 Year Return –81. 02 compared to CAD 0. *Close price adjusted for splits. The Company's initial focus is to support mental health. A copy of PanGenomic Health's financial statements for the year ended December 31, 2022 and the related Management's Discussion and Analysis is available on under PanGenomic Health's profile on. At the top left are shown families from the dispensable genome and singletons. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Discover historical prices for NARA. 08%. (NARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Die DWS Group (DWS) ist einer der weltweit führenden Vermögensverwalter. A3DN26. Employees. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of. Announces that further to its news release of September 1, 2022, it has entered into a definitive share. Kurs Meyer Burger Technology 0,2594 EUR22 Apr 2023, 07:10. 23, 2023 /CNW/ - PanGenomic Health Inc. DAX Liste Realtime Indikation. Sie wird über das gesamte Spektrum der Anlagedisziplinen hinweg als. About PanGenomic Health. CARDINAL HEALTH AKTIE und aktueller Aktienkurs. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed financial statements for the six month period ended June 30, 2023 (the "First Half 2023 Financial Statements"). Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. 22, 2022 /CNW/ - PanGenomic Health Inc. Zuletzt verteuerte sich das. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. 12, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Übersicht Deine Holdings (0) Dividenden AnalysenFor several years, I’ve been working to change the world of healthcare by leveraging the power of tech, an effort that has landed me on the diverse and passionate team behind PanGenomic Health. is a precision health company. HP AKTIE und aktueller Aktienkurs. Aktie Pangenomic Health Inc. nasdaq 100. . PANGENOMIC HEALTH A Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zu A3DN26 - CA69842E2050 - Realtimekurse VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. 12 April 2022. Loading more data. Log in to view data. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 0212 set on Aug 22, 2023. -4,11 %. ADRs) 21Vianet Group Inc. 23, 2022 /CNW/ - PanGenomic Health Inc. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic ISIN CA69842E2050. ADRs) Westag & Getalit AG (Vz. PANGENOMIC HEALTH A Bilanz - hier erhalten Sie ausführliche Bilanzinformationen zur PANGENOMIC HEALTH A Aktie. (“PanGenomic” or the “Company”) (CSE: NARA), is pleased to announce that it has initiated a non-brokered private placement financing of up to 3,333,333 units (each a. A3DMEG. 778 743 4642. VANCOUVER, BC, July 13, 2023 /CNW/ - PanGenomic Health Inc. (dba Bello Capital Partners), 310 Water Street, Suite 306, Vancouver, BC V6B1B6, 604 417 4440,. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Reports Earnings Results for the Full Year Ended December 31, 2022. CN) stock quote, history, news and other vital. Nachrichten zur PANGENOMIC HEALTH A Aktie - Aktuelle TOP-Meldungen - Die wichtigsten PANGENOMIC HEALTH A News im Überblick - seriös, schnell und kompetent. 17 Following. Die Nutzung der comdirect-Website ist ohne JavaScript nicht möglich. Aktuelle Empfehlungen zur PANGENOMIC HEALTH Aktie. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. DTCFF. Analyst. PanGenomic Health Inc. 778 743 4642. PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services (the "Services"). , 778 743 4642, [email. nasdaq 100. (CSE: NARA) today issued a letter to shareholders from its executive team. A3CN14. PanGenomic Health Inc. En tant qu'entreprise de bienfaisance. +/-%. The Company's initial focus is to support mental health. Pangenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. Mindleap-App von PanGenomic Health wird zur All-in-One-App und Telemedizin-Plattform für ganzheitliche psychische Gesundheit und Resilienz ausgebautPangenomic Health Inc. Popular. (“MUJN Diagnostics”), has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service and. MICROSOFT AKTIE und aktueller Aktienkurs. Own your health journey. Realtime Aktienkurs der PanGenomic Health Aktie mit Live-Chart inkl. [email protected] Jones 30 Industrial, NASDAQ Composite Index, S&P 500, NASDAQ 100, S&P 100, BX Swiss - USA. The two companies are jointly. VCHC provides wellness treatments, health education, Community Nursing Services &. CA69842E2050. Mit der TradingView Desktop Anwendung können Sie sich mit Ihrem Browser bei Ihrem Konto anmelden und alle Funktionen nutzen. 09:30:00 2023-10-31 am EDT 5-day change. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 Aug. Pangenomic Health also announces that its Nara app now also. N-N6kQrkeXBQV39vtKCgMFC0uimY_VLCNyX7dlB17Y8. ("MUJN Diagnostics"), has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service and completed its first sale of the point-of. By continuing to use our service, you agree to our use of cookies. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PANGENOMIC HEALTH A Chartanalyse und Chartsignale - Entwicklung Long-Short Ratio PANGENOMIC HEALTH A Aktie - Alle Signale verschiedener Trading-StrategienPanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc. Pangenomic Health A Realtimekurs. PanGenomic Health Inc. com. to Pangenomic Health Inc. MUJN Diagnostics Inc. PanGenomic Health Inc. Sie blickt auf mehr als 60 Jahre Erfahrung zurück und ist in Deutschland und Europa für ihre exzellenten Leistungen bekannt. %. Free real-time prices, and the most active stock market forums in the UK. The common shares of PanGenomic Health Inc. PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement PR Newswire LONDON, United Kingdom, November 02 2 November 2023 PanGenomic Health. PanGenomic Health Inc. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. 17, 2023 /CNW/ - PanGenomic Health Inc. EGF THERAMED HEALTH AKTIE und aktueller Aktienkurs. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. EVAHF. VANCOUVER, BC, Nov. 0,0210. com This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by. View real. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. MYDECINE INNOVATIONS Group Inc. PanGenomic is a health-tech company with an AI platform that supports consumer applications offering Telehealth, and diagnostic tools designed to improve quality and accessibility of care for. Love this for my natural remedy guide I never know what I should get or how to use it and Nara does that all for me perfectly. ftse-100 PANGENOMIC HEALTH A Analysen - hier finden Sie eine Übersicht aller relevanter Aktienanalysen zur PANGENOMIC HEALTH A Aktie von Banken, Investmenthäusern und Medien. PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement. (A) (spons. operates as a precision health company. 2 Ratings. Business Update. MEYER BURGER WKN: A0YJZX ISIN: CH0108503795 Kürzel: MBTN Forum: Aktien Thema: Hauptdiskussion. Pangenomic Health A Aktie. S&P 500. Empfehlungen der Analysten zur PANGENOMIC HEALTH Aktie. 04 CAD. Redcare Pharmacy Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie (RDC) • NL0012044747 (A2AR94) • Handel • VersandhandelBMW AKTIE und aktueller Aktienkurs. Portfolio Tracking Watchlists Märkte Dividendenkalender Neu Community Blog Registrieren Anmelden Aktie. Pangenomic Health Inc. Seite 1 der Diskussion 'Wird PanGenomic Health der neue Star am Mobile Medical. S. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. PanGenomic Health Inc. 30 Day Avg Volume 100,118. Aktienverlauf & Wertentwicklung. See other industries within the Information sector: All Other Telecommunications , Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services , Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers , Motion Picture and Video Industries , Newspaper, Periodical, Book,. . , 778 743 4642, info@pangenomic. Basic loss per share from continuing operations was CAD 0. PanGenomic Health Inc. PanGenomic Health Inc. Aktie. Analyst Potential (Euro) Potential Zeit; Aktuell sind keine Analysen verfügbar, die den gewählten Kriterien entsprechen. operates as a precision health company. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. com; Maryam Marissen, President & CEO, PanGenomic Health Inc. 0,024. 0350 (unch) PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants Newswire. $1. 04/05/2023 08:04:49 Cookie Policy +44 (0) 203 8794 460. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. 30, 2023 /CNW/ - PanGenomic Health Inc. 25 Tage Jubiläumsparty: Jetzt mitmachen und täglich neue Gewinnchance sichern. A publicly-traded benefit corporation (CSE:NARA). (formerly named PlantGx Diagnostics Corp. VANCOUVER, BC, March 2, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. /Not for distribution to U. Pangenomic Health Inc. Alle Nutzer können den Diskussionen auf Investing. —. (PAN) auf einem Forum, das sich mit der Entwicklung von Impfstoffen und Therapien für Krebs befasst. operates as a health care platform company. Fobi AI Stock (TSXV:FOBI) opened trading at C$0. -0,87%. CN stock on Yahoo Finance. David Joshua Bartch is an entrepreneur and businessperson who founded Doctors Orders LLC, Audiotranscriptionist Com and Revolutionary Software LLC and who has been at the helm of 7 different companies. The company has a very good potential for expansion. Einstellbar sind verschiedene Zeiträume, Charttypen und Indikatoren. Jetzt im Neujahr sehe ich, dass dieser Verlust nicht mehr da ist. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. As well, Fobi reported that it has granted, pursuant to its Stock Option Plan, a total of 3,814,892 stock options to several company employees and officers to purchase. PanGenomic Health Inc. Official Data Partner. The Company's initial. ISIN. Tweets. The Company's initial. VANCOUVER, BC, March 8, 2023 /CNW/ - PanGenomic. 616M. ("PlantGx"), has signed a development partnership. 31, 2023 /CNW/ - PanGenomic Health Inc. Own your health journey . , has signed an agreement to lease space at Psy Integrated Health. PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement PR Newswire LONDON, United Kingdom, November 02 2 November 2023 PanGenomic Health. PanGenomic. PanGenomic Health Corp. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), announced today that independent directors, Peter Green and Jonathan Lutz, tendered their resignations. (TSMC) (Spons. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere mit wallstreetONLINE Pangenomic Health Registered (A) Aktie. PanGenomic Health Inc. Other stock markets. Pangenomic Health Inc schüttet keine Dividende aus. com info@pangenomic.